New SEC Form D filing

Superior Genomics, Inc., 2026-08-14

A new SEC Form D private-offering notice from Norway, MI, a $1,500,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Superior Genomics, Inc. site↗ Verified via SEC Form D

Develops blood tests using gene expression biomarkers to diagnose mental health conditions such as major depressive disorder and bipolar disorder

Filed 5 days agoFiled to raise $1,500,000First money in 2026-07-30Raised so far $507,500HQ (as filed) Norway, MISector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified superiorgenomics.com↗Named in the filing 2 executives & directors
Open this row on the live feed →More new filings in Michigan →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source